Circulation, ISSN 0009-7322, 05/2018, Volume 137, Issue 21, pp. 2309 - 2309
Journal Article
Circulation, ISSN 0009-7322, 05/2018, Volume 137, Issue 21, pp. 2309 - 2309
Journal Article
Circulation, 05/2018, Volume 137, Issue 21, p. 2309
Journal Article
Advances in Experimental Medicine and Biology, ISSN 0065-2598, 2017, Volume 1051, pp. 123 - 138
Journal Article
Advances in experimental medicine and biology, ISSN 0065-2598, 2017, Volume 1051, p. 123
P2Y receptors are G-protein-coupled receptors (GPCRs) for extracellular nucleotides. The platelet ADP-receptor which has been denominated P2Y receptor is an...
Blood Platelets - pathology | Asthma - metabolism | Muscle, Smooth, Vascular - metabolism | Atherosclerosis - genetics | Humans | GTP-Binding Protein alpha Subunit, Gi2 - metabolism | Structure-Activity Relationship | Brain Injuries - metabolism | Alzheimer Disease - pathology | GTP-Binding Protein alpha Subunit, Gi2 - genetics | rap GTP-Binding Proteins - genetics | Protein Domains | Receptors, Purinergic P2Y12 - metabolism | Receptors, Purinergic P2Y12 - genetics | Atherosclerosis - pathology | Brain Injuries - genetics | Asthma - genetics | Atherosclerosis - metabolism | Platelet Aggregation | Receptors, Purinergic P2Y12 - chemistry | Muscle, Smooth, Vascular - pathology | Animals | Blood Platelets - metabolism | Alzheimer Disease - metabolism | Alzheimer Disease - genetics | rap GTP-Binding Proteins - metabolism | Asthma - pathology | Brain Injuries - pathology
Blood Platelets - pathology | Asthma - metabolism | Muscle, Smooth, Vascular - metabolism | Atherosclerosis - genetics | Humans | GTP-Binding Protein alpha Subunit, Gi2 - metabolism | Structure-Activity Relationship | Brain Injuries - metabolism | Alzheimer Disease - pathology | GTP-Binding Protein alpha Subunit, Gi2 - genetics | rap GTP-Binding Proteins - genetics | Protein Domains | Receptors, Purinergic P2Y12 - metabolism | Receptors, Purinergic P2Y12 - genetics | Atherosclerosis - pathology | Brain Injuries - genetics | Asthma - genetics | Atherosclerosis - metabolism | Platelet Aggregation | Receptors, Purinergic P2Y12 - chemistry | Muscle, Smooth, Vascular - pathology | Animals | Blood Platelets - metabolism | Alzheimer Disease - metabolism | Alzheimer Disease - genetics | rap GTP-Binding Proteins - metabolism | Asthma - pathology | Brain Injuries - pathology
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 2006, Volume 110, Issue 3, pp. 415 - 432
Membrane-bound P2-receptors mediate the actions of extracellular nucleotides in cell-to-cell signalling. P2X-receptors are ligand-gated ion channels, whereas...
Prasugrel | MRS2567 | Cangrelor | P2Y receptor | MRS2279 | Subtype-selective antagonists | MRS2179 | Clopidogrel | clopidogrel | PLATELET ADP RECEPTOR | URIDINE NUCLEOTIDE RECEPTOR | prasugrel | DEOXYADENOSINE BISPHOSPHATE DERIVATIVES | cangrelor | HUMAN P2Y RECEPTOR | SITE-DIRECTED MUTAGENESIS | P2 RECEPTORS | PROTEIN-COUPLED RECEPTOR | FUNCTIONAL EXPRESSION | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | subtype-selective antagonists | HUMAN MAST-CELLS | Amino Acid Sequence | Receptors, Purinergic P2 - chemistry | Animals | Signal Transduction | Species Specificity | Humans | Cloning, Molecular | Molecular Sequence Data | Purinergic P2 Receptor Antagonists | Ligands | Receptors, Purinergic P2 - physiology | Purinergic P2 Receptor Agonists | Adenylate cyclase | Coenzymes | RNA | Heterocyclic compounds | Cloning | Angiotensin | Cellulose | Physiological aspects | Nucleosides | Nucleotides | Peptide hormones
Prasugrel | MRS2567 | Cangrelor | P2Y receptor | MRS2279 | Subtype-selective antagonists | MRS2179 | Clopidogrel | clopidogrel | PLATELET ADP RECEPTOR | URIDINE NUCLEOTIDE RECEPTOR | prasugrel | DEOXYADENOSINE BISPHOSPHATE DERIVATIVES | cangrelor | HUMAN P2Y RECEPTOR | SITE-DIRECTED MUTAGENESIS | P2 RECEPTORS | PROTEIN-COUPLED RECEPTOR | FUNCTIONAL EXPRESSION | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | subtype-selective antagonists | HUMAN MAST-CELLS | Amino Acid Sequence | Receptors, Purinergic P2 - chemistry | Animals | Signal Transduction | Species Specificity | Humans | Cloning, Molecular | Molecular Sequence Data | Purinergic P2 Receptor Antagonists | Ligands | Receptors, Purinergic P2 - physiology | Purinergic P2 Receptor Agonists | Adenylate cyclase | Coenzymes | RNA | Heterocyclic compounds | Cloning | Angiotensin | Cellulose | Physiological aspects | Nucleosides | Nucleotides | Peptide hormones
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 05/2009, Volume 52, Issue 9, pp. 2762 - 2775
The P2Y2 receptor, which is activated by UTP, ATP, and dinucleotides, was studied as a prototypical nucleotide-activated GPCR. A combination of receptor...
Journal Article
Neuropharmacology, ISSN 0028-3908, 05/2016, Volume 104, pp. 50 - 61
P2Y receptors are G-protein-coupled receptors (GPCRs) for extracellular nucleotides. There are eight mammalian P2Y receptor subtypes (P2Y , P2Y , P2Y , P2Y ,...
Uracil nucleotides | Adenine nucleotides | P2Y receptors | Platelet aggregation | Inflammation | Receptor ligands | Neuromodulation | Crystal structure | PLATELET ADP RECEPTOR | ATP RECEPTOR | HUMAN P2Y RECEPTOR | NEUROSCIENCES | PROTEIN-COUPLED RECEPTOR | REVERSE CHOLESTEROL TRANSPORT | ADENYLYL-CYCLASE | PHARMACOLOGY & PHARMACY | MOLECULAR-CLONING | PURINERGIC RECEPTOR | HUMAN MAST-CELLS | URACIL NUCLEOTIDE DERIVATIVES | Purinergic P2Y Receptor Antagonists - pharmacology | Microglia - metabolism | Receptors, Purinergic P2Y - chemistry | Uridine Triphosphate - metabolism | Cardiovascular Diseases - metabolism | Humans | Receptors, Purinergic P2Y - metabolism | Neurodegenerative Diseases - metabolism | Receptors, Purinergic P2Y - physiology | Purinergic P2Y Receptor Agonists - pharmacology | Brain - metabolism | Platelet Aggregation | Animals | Adenosine Triphosphate - metabolism | Neurons - metabolism | Adenosine Diphosphate - metabolism | Physiological aspects | Purines | Pharmacology | Nucleotides | Structure | Crystals | Pyrimidines
Uracil nucleotides | Adenine nucleotides | P2Y receptors | Platelet aggregation | Inflammation | Receptor ligands | Neuromodulation | Crystal structure | PLATELET ADP RECEPTOR | ATP RECEPTOR | HUMAN P2Y RECEPTOR | NEUROSCIENCES | PROTEIN-COUPLED RECEPTOR | REVERSE CHOLESTEROL TRANSPORT | ADENYLYL-CYCLASE | PHARMACOLOGY & PHARMACY | MOLECULAR-CLONING | PURINERGIC RECEPTOR | HUMAN MAST-CELLS | URACIL NUCLEOTIDE DERIVATIVES | Purinergic P2Y Receptor Antagonists - pharmacology | Microglia - metabolism | Receptors, Purinergic P2Y - chemistry | Uridine Triphosphate - metabolism | Cardiovascular Diseases - metabolism | Humans | Receptors, Purinergic P2Y - metabolism | Neurodegenerative Diseases - metabolism | Receptors, Purinergic P2Y - physiology | Purinergic P2Y Receptor Agonists - pharmacology | Brain - metabolism | Platelet Aggregation | Animals | Adenosine Triphosphate - metabolism | Neurons - metabolism | Adenosine Diphosphate - metabolism | Physiological aspects | Purines | Pharmacology | Nucleotides | Structure | Crystals | Pyrimidines
Journal Article
Scandinavian Journal of Gastroenterology, ISSN 0036-5521, 2007, Volume 42, Issue 9, pp. 1045 - 1053
Objective. Sequencing efforts to discover mutations in the tyrosine kinase Kit related to systemic mast cell disorders have so far been focused mainly on only...
Gastrointestinal stromal cell tumor | mast cell activation disorder | Kit tyrosine kinase | mast cell mediator syndrome | irritable bowel disease | Mast cell mediator syndrome | Irritable bowel disease | Mast cell activation disorder | GENE-MUTATIONS | SITE | ISOFORMS | C-KIT | ACUTE MYELOID-LEUKEMIA | STROMAL TUMORS | gastrointestinal stromal cell tumor | RECEPTOR DIMERIZATION | MASTOCYTOSIS | IMATINIB | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Mastocytosis - diagnosis | Humans | Middle Aged | Male | Mastocytosis - genetics | Syndrome | Point Mutation - genetics | Gastrointestinal Diseases - genetics | RNA Splicing - genetics | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Aged
Gastrointestinal stromal cell tumor | mast cell activation disorder | Kit tyrosine kinase | mast cell mediator syndrome | irritable bowel disease | Mast cell mediator syndrome | Irritable bowel disease | Mast cell activation disorder | GENE-MUTATIONS | SITE | ISOFORMS | C-KIT | ACUTE MYELOID-LEUKEMIA | STROMAL TUMORS | gastrointestinal stromal cell tumor | RECEPTOR DIMERIZATION | MASTOCYTOSIS | IMATINIB | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Mastocytosis - diagnosis | Humans | Middle Aged | Male | Mastocytosis - genetics | Syndrome | Point Mutation - genetics | Gastrointestinal Diseases - genetics | RNA Splicing - genetics | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Aged
Journal Article
10.
Full Text
Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors
Nature, ISSN 0028-0836, 12/2014, Volume 516, Issue 7531, pp. 395 - 399
Brown adipose tissue (BAT) is specialized in energy expenditure, making it a potential target for anti-obesity therapies. Following exposure to cold, BAT is...
Cricetinae | Phenethylamines - pharmacology | Humans | Mice, Inbred C57BL | Cells, Cultured | Male | Adenosine - pharmacology | Receptor, Adenosine A2A - metabolism | Animals | Adenosine A2 Receptor Agonists - pharmacology | Diet | Adenosine - analogs & derivatives | Adipocytes - metabolism | Mesocricetus | Adenosine - metabolism | Adipose Tissue, Brown - drug effects | Adipose Tissue, Brown - metabolism | Mice | Brown adipose tissue | Adenosine | Research | Health aspects | Rodents | Index Medicus
Cricetinae | Phenethylamines - pharmacology | Humans | Mice, Inbred C57BL | Cells, Cultured | Male | Adenosine - pharmacology | Receptor, Adenosine A2A - metabolism | Animals | Adenosine A2 Receptor Agonists - pharmacology | Diet | Adenosine - analogs & derivatives | Adipocytes - metabolism | Mesocricetus | Adenosine - metabolism | Adipose Tissue, Brown - drug effects | Adipose Tissue, Brown - metabolism | Mice | Brown adipose tissue | Adenosine | Research | Health aspects | Rodents | Index Medicus
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2019
Journal Article
Brain Research Bulletin, ISSN 0361-9230, 09/2019, Volume 151, pp. 12 - 24
P2Y receptors are G-protein-coupled receptors (GPCRs) for extracellular nucleotides. There are eight mammalian P2Y receptor subtypes divided into two subgroups...
Uracil nucleotides | P2Y receptors | Receptor ligands | Adenine nucleotides | Crystal structure | PLATELET ADP RECEPTOR | PHOSPHOLIPASE-C | HIGH-AFFINITY | HUMAN P2Y RECEPTOR | SITE-DIRECTED MUTAGENESIS | NEUROSCIENCES | PROTEIN-COUPLED RECEPTOR | SMOOTH-MUSCLE-CELLS | MOLECULAR-CLONING | PURINERGIC RECEPTOR | URACIL NUCLEOTIDE DERIVATIVES | Aggregation | Pyrimidines | Metabolites | Blood platelets | Analysis | Crystals | Physiological aspects | Cellular signal transduction | Pharmacology | Inflammation | Nucleotides | Structure
Uracil nucleotides | P2Y receptors | Receptor ligands | Adenine nucleotides | Crystal structure | PLATELET ADP RECEPTOR | PHOSPHOLIPASE-C | HIGH-AFFINITY | HUMAN P2Y RECEPTOR | SITE-DIRECTED MUTAGENESIS | NEUROSCIENCES | PROTEIN-COUPLED RECEPTOR | SMOOTH-MUSCLE-CELLS | MOLECULAR-CLONING | PURINERGIC RECEPTOR | URACIL NUCLEOTIDE DERIVATIVES | Aggregation | Pyrimidines | Metabolites | Blood platelets | Analysis | Crystals | Physiological aspects | Cellular signal transduction | Pharmacology | Inflammation | Nucleotides | Structure
Journal Article
Cardiovascular Research, ISSN 0008-6363, 04/2011, Volume 90, Issue 1, pp. 148 - 156
Extracellular adenosine and adenine nucleotides play important roles in the regulation of the blood vessel tonus and platelet aggregation. Less is known about...
receptor | Arterial smooth muscle cell | Proliferation | Exchange protein activated by cAMP | Nuclear factor NR4A1 | Adenosine A | Immunohistochemistry | Up-Regulation | Muscle, Smooth, Vascular - metabolism | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Coronary Vessels - metabolism | Dose-Response Relationship, Drug | Transfection | Adenosine A2 Receptor Agonists - pharmacology | RNA Interference | Time Factors | Guanine Nucleotide Exchange Factors - metabolism | Receptor, Adenosine A2B - drug effects | Adult | Female | Myocytes, Smooth Muscle - drug effects | Cyclic AMP - metabolism | Myocytes, Smooth Muscle - metabolism | Muscle, Smooth, Vascular - drug effects | Nuclear Receptor Subfamily 4, Group A, Member 1 - genetics | Signal Transduction | Cells, Cultured | Gene Expression Profiling - methods | Reverse Transcriptase Polymerase Chain Reaction | Receptor, Adenosine A2B - metabolism | Adenosine A2 Receptor Antagonists - pharmacology | Adenosine - metabolism | Nuclear Receptor Subfamily 4, Group A, Member 1 - metabolism | Aged | Cell Proliferation - drug effects
receptor | Arterial smooth muscle cell | Proliferation | Exchange protein activated by cAMP | Nuclear factor NR4A1 | Adenosine A | Immunohistochemistry | Up-Regulation | Muscle, Smooth, Vascular - metabolism | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Coronary Vessels - metabolism | Dose-Response Relationship, Drug | Transfection | Adenosine A2 Receptor Agonists - pharmacology | RNA Interference | Time Factors | Guanine Nucleotide Exchange Factors - metabolism | Receptor, Adenosine A2B - drug effects | Adult | Female | Myocytes, Smooth Muscle - drug effects | Cyclic AMP - metabolism | Myocytes, Smooth Muscle - metabolism | Muscle, Smooth, Vascular - drug effects | Nuclear Receptor Subfamily 4, Group A, Member 1 - genetics | Signal Transduction | Cells, Cultured | Gene Expression Profiling - methods | Reverse Transcriptase Polymerase Chain Reaction | Receptor, Adenosine A2B - metabolism | Adenosine A2 Receptor Antagonists - pharmacology | Adenosine - metabolism | Nuclear Receptor Subfamily 4, Group A, Member 1 - metabolism | Aged | Cell Proliferation - drug effects
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 05/2017, Volume 60, Issue 9, pp. 3636 - 3655
The Gi protein-coupled receptor GPR84, which is activated by (hydroxy)fatty acids, is highly expressed on immune cells. Recently, 3,3′-diindolylmethane was...
BREAST-CANCER CELLS | 3,3'-DIINDOLYLMETHANE DERIVATIVES | CHEMISTRY, MEDICINAL | SOLVENT-FREE CONDITIONS | CHAIN FATTY-ACIDS | CATALYZED-REACTIONS | PROSTATE-CANCER | EFFICIENT SYNTHESIS | CARBONYL-COMPOUNDS | FUNCTIONAL-CHARACTERIZATION | REDUCTIVE C-ALKYLATION | C
BREAST-CANCER CELLS | 3,3'-DIINDOLYLMETHANE DERIVATIVES | CHEMISTRY, MEDICINAL | SOLVENT-FREE CONDITIONS | CHAIN FATTY-ACIDS | CATALYZED-REACTIONS | PROSTATE-CANCER | EFFICIENT SYNTHESIS | CARBONYL-COMPOUNDS | FUNCTIONAL-CHARACTERIZATION | REDUCTIVE C-ALKYLATION | C